Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Israeli Innovation Shown to Demonstrate Reduction in Headaches and Neck Pain

November 26, 2012

TEL AVIV, Israel, November 26, 2012 /PRNewswire/ –

Israel-based medical device company Headway medical
[http://www.headwaymedical.com/Homepage ] reports the successful completion of a series of
clinical trials of Occiflex, its innovative therapeutic table designed to reduce chronic
neck pain and headaches. The device will be available, starting in 2013, to physiotherapy
clinics and rehabilitation centers throughout the world.

A revolutionary new device based on the principles of physiotherapy, Occiflex supports
slow, repeated, and precise treatment for patients with muscle-dysfunction-related chronic
pain. The Occiflex table mechanism allows physiotherapists to devise a manual mobilization
file that is tailored to the needs of each patient, and, since it does not depend on the
therapist’s physical abilities, it can continue therapy for much longer than is standard
and possible today. Plus, since each patient’s therapy protocol is saved in a database,
treatment can be reproduced precisely each time. The patient’s file can be modified at any
time, as conditions changes. The Occiflex treatment table improves the condition of the
cervical joints, muscle, ligaments, and central nervous system control over the neck and
head.

The Clinical Journal of Pain recently published a scientific article
[http://www.upsite.co.il/uploaded/files/1302_e521d3c3422d1290180b674011930cbb.pdf ] that
describes the clinical trial conducted by Headway in the physiotherapy department of the
Bnei Zion Medical Center in Haifa, Israel. The trial tested the advanced prototype
developed by the company. Results indeed demonstrated a reduction of chronic neck pain in
the patients and increased mobility.

According to Tamir Levital, CEO of Headway, “Occiflex will make the work of 50,000
physiotherapy and pain centers around the world more efficient and provide relief for the
hundreds of millions who suffer from chronic neck pain and headaches. It will also save
physiotherapists time and energy, and permit them to treat a number of patients
simultaneously. The results of our trials show that Occiflex permits more precise,
effective, repeated, and longer treatment than is possible today. We are very happy with
the results of the trial and are getting ready to market Occiflex starting in 2013.”

Headway, which got its start in the Misgav Venture Accelerator (owned by the
Trendlines Group), was founded in 2006 by Dr. Yaron River, chief physician at the
Neurology Department, Hillel Yaffe Medical Center, Hadera. The company has raised $1.5
million from private investors, the Misgav Venture Accelerator, and government R&D grants.

        Media relations:
        Efrat Kaduri
        Ofir Shpigel Media and Public Relations
        +972-4-9535030

SOURCE Headway Medical


Source: PR Newswire